1 April 2021
Infex focuses on pandemic preparedness with Covid patent
Infex Therapeutics has filed for a UK patent for a novel therapy designed to tackle all coronavirus strains. The COV-X program targets a protein which is essential for viral replication across a broad spectrum of related coronaviruses, including SARS-CoV-1, MERS-CoV and...
26 March 2021
Healum closes investment round to develop UKRI funded AI powered patient management system for people with long term conditions
MANCHESTER, UK, 25th March 2021 - Healum, a leading digital health company, known for developing a ground-breaking AI powered patient management system to improve health outcomes and quality of life for people with long term conditions, has raised funding from NPIF – Maven...
25 March 2021
Panthera Biopartners commences a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19
Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site … Panthera is running a double-blind, placebo-controlled trial of AstraZeneca’s AZD7422...
8 March 2021
UK healthtech startup Rinicare appoints leading AI and machine learning specialist as Chief Technology and Data Officer
Manchester-based clinician-led digital health company, Rinicare, has appointed AI and machine learning specialist Miguel Mendao as its Chief Technology and Data Officer to help further develop its impressive portfolio of AI-driven technologies for healthcare. Rinicare Managing...
1 March 2021
Panthera further strengthens its oncology clinical trials team with the appointment of Matt Cooper as General Manager Oncology
Panthera Biopartners, an independent SMO (Site Management Organisation), has appointed Matt Cooper as General Manager, Oncology. Matt has extensive experience in the recruitment and running of clinical trials in oncology. Until recently, Matt has been Chief Operating Officer of...
25 February 2021
Biorelate signs multi-year deal with e-therapeutics
Biorelate has announced a new 3 year contract with e-therapeutics PLC for Galactic Data. After 2 successful years of collaboration, Biorelate will continue to provide auto-curated cause-and-effect data to fuel e-therapeutics’ data-driven discovery platform. Jonny Wray (CTO...
24 February 2021
Cytox launches genoSCORE-LAB test to predict the risk of developing Alzheimer’s disease
Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from home … Test can guide lifestyle interventions to potentially slow disease progression … 24th February 2021:
16 February 2021
The pill could be sold in pharmacies without prescription
Some contraceptive pills could be sold over the counter in the UK for the first time, the government has said. It is asking the public for their views on whether two progestogen-only pills, also known as the "mini-pill", should be available without prescription. The move has...
11 February 2021
Maxwellia spearheading shift to self-care with three pharmacy products in launch pipeline
Push to convert more prescription medicines to over-the-counter will put pharmacists at heart of nation's public health, helping futureproof NHS … LONDON, Feb. 11, 2021 - Pioneering pharma company Maxwellia is poised to transform the UK's self-care market by giving people easier...
11 February 2021
Maxwellia announces appointment of Tim Holmes as Head of Sales
Maxwellia, the UK’s only dedicated expert medicines switching company, has appointed Tim Holmes to the newly created role of Head of Sales with responsibility for building the company’s customer strategy and customer success model. The appointment is the second so...